We examined the relationship between gene expression of ROR1 and/or ROR2 and outcomes in breast cancer patients enrolled in the “Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And Molecular Analysis 2” (I-SPY2 TRIAL) study. This evidence concerns the gene ROR2 and breast carcinoma.